Physician profile
Muhammad Mustafa
NPI 1649215989
$11,131.10
in general payments reported to CMS, 2019-2025
37 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,513 · 2020: $887 · 2021: $982 · 2022: $870 · 2023: $631 · 2024: $749 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877 · Education: $3.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.96 |
| Education | $3.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,292.54 | 2019 | |
| Abbott Laboratories | $962.79 | 2019-2024 | Jot Dx |
| Merck Sharp & Dohme LLC | $511.73 | 2021-2025 | Verquvo, Steglatro |
| Novartis Pharmaceuticals Corporation | $510.73 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $483.58 | 2019-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $482.52 | 2019-2022 | |
| Amgen INC. | $462.27 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $349.65 | 2019-2023 | Lifevest |
| Medtronic, INC. | $321.06 | 2021-2023 | Onyx Frontier |
| Pfizer INC. | $274.33 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.99 | 2019-2025 | Jardiance |
| Biotronik INC. | $134.13 | 2024 | Amvia Edge, Pulsar-18 T3 |
| E.R. Squibb & Sons, L.L.C. | $133.16 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $120.29 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $83.10 | 2024 | Arcalyst |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $80.88 | 2019-2022 | |
| Amarin Pharma, INC. | $73.23 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $70.70 | 2022-2023 | Arcalyst |
| Recor Medical INC | $65.49 | 2024 | Paradise Renal Denervation System |
| Boston Scientific Corporation | $64.12 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $49.79 | 2024 | Assure Wcd |
| Laborie Medical Technologies Corp. | $49.31 | 2024 | |
| Arbor Pharmaceuticals, INC. | $48.20 | 2019 | |
| Baxter Healthcare | $44.69 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Daiichi Sankyo INC. | $42.48 | 2019 | |
| Abiomed | $34.24 | 2019-2023 | Impella |
| Preventice Services, LLC | $33.87 | 2021 | |
| Bridgebio Pharma, INC. | $30.67 | 2025 | Attruby |
| Cook Medical LLC | $23.11 | 2024 | Zilver Vena, Amplatz |
| Merit Medical Systems INC | $19.28 | 2025 | |
| Medicomp INC | $18.77 | 2025 | Telepatch Cardiac Monitor |
| Cardiovascular Systems INC. | $16.52 | 2020 | |
| Cvrx, INC. | $16.26 | 2024 | Barostim Neo System |
| Gilead Sciences, INC. | $11.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.96 | 2019 | |
| Altathera Pharmaceuticals LLC | $9.86 | 2022 | |
| Bardy Diagnostics, INC. | $5.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Mustafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.